01:31 AM EST, 11/09/2026 (MT Newswires) -- Middle East Pharmaceutical Industries Co. (SASE:4016), d/b/a Avalon Pharma, obtained a 60 million-Saudi-riyal credit facility from the Saudi Industrial Development Fund. The facility has a duration of two years, with the funds to be used as working capital, the Tadawul-listed pharmaceutical company said Monday.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.